Decreased mRNA and protein stability of W1282X limits response to modulator therapy.

MLA

Aksit, M. A., et al. “Decreased MRNA and Protein Stability of W1282X Limits Response to Modulator Therapy.” Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society, vol. 18, no. 5, Sept. 2019, pp. 606–13. EBSCOhost, https://doi.org/10.1016/j.jcf.2019.02.009.

APA

Aksit, M. A., Bowling, A. D., Evans, T. A., Joynt, A. T., Osorio, D., Patel, S., West, N., Merlo, C., Sosnay, P. R., Cutting, G. R., & Sharma, N. (2019). Decreased mRNA and protein stability of W1282X limits response to modulator therapy. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society, 18(5), 606–613. https://doi.org/10.1016/j.jcf.2019.02.009

Chicago

Aksit, M A, A D Bowling, T A Evans, A T Joynt, D Osorio, S Patel, N West, et al. 2019. “Decreased MRNA and Protein Stability of W1282X Limits Response to Modulator Therapy.” Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society 18 (5): 606–13. doi:10.1016/j.jcf.2019.02.009.